Stocks Health care SIBN
NASDAQ · Health careSI-BONE, Inc. (SIBN)
SI-BONE, Inc. brought in $220.7M of revenue over the twelve months to September 30, 2026, up 14.0% from a year earlier. It posted a net loss of $13.7M. In fiscal 2025 capital spending exceeded operating cash flow by $9.1M. At September 30, 2026 it held $35.3M in cash against $35.7M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 3, 2026.
Key facts about SI-BONE, Inc.
- Net worth
- SI-BONE, Inc. has a market value (market cap) of $1.1B at the latest share price, and shareholders' equity of $184.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $200.9M (+20.2% year on year), with a net loss of $18.9M. Over the 12 months to September 30, 2026: revenue $220.7M, net loss $13.7M.
- Cash flow
- In fiscal 2025 operations used $675K of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 3, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- SI-BONE, Inc.'s next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What SI-BONE, Inc. does
SI-BONE, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker SIBN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $200.9M | -$18.9M | -$0.44 | -$9.1M |
| 2024 | $167.2M | -$30.9M | -$0.75 | -$22.9M |
| 2023 | $138.9M | -$43.3M | -$1.13 | -$26.5M |
| 2022 | $106.4M | -$61.3M | -$1.79 | -$51.2M |
| 2021 | $90.2M | -$56.6M | -$1.71 | -$45.9M |
| 2020 | $73.4M | -$43.7M | -$1.50 | -$33.2M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where SIBN ranks in Health care
Latest SEC filings
What SI-BONE, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 3, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 14% to $55.7M versus the same quarter last year; diluted EPS -$0.08 versus -$0.11.
- November 2, 2026
- September 11, 2026
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 4, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 15% to $56M versus the same quarter last year; diluted EPS -$0.09 versus -$0.14.
- August 3, 2026
- July 30, 2026Passive stake changed SCHEDULE 13G/A
- June 8, 2026
- May 11, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 11% to $52.6M versus the same quarter last year; diluted EPS -$0.10 versus -$0.15.
- May 11, 2026
Insider trades
What the people running SI-BONE, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $8.3M worth of shares in the last 90 days and bought none on the open market. Most of the selling (94%) was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 4, 2026 | Pisetsky Michael A.SVP, Ops & Adm/Chief Legal Ofr | Exercised options | 9,347 | $205.6K |
| November 4, 2026 | Pisetsky Michael A.SVP, Ops & Adm/Chief Legal Ofr | Exercised options | 3,002 | $66K |
| November 4, 2026 | Pisetsky Michael A.SVP, Ops & Adm/Chief Legal Ofr | Soldpre-planned (10b5-1) | 12,349 | $309.7K |
| November 4, 2026 | Pisetsky Michael A.SVP, Ops & Adm/Chief Legal Ofr | Soldpre-planned (10b5-1), indirect | 23,892 | $592.2K |
| November 4, 2026 | Francis LauraChief Executive Officer, Director | Soldpre-planned (10b5-1), indirect | 75,000 | $1.9M |
| November 4, 2026 | Maheshwari AnshulChief Op & Financial Officer | Soldpre-planned (10b5-1) | 3,247 | $81.2K |
| November 2, 2026 | Dunn Jeffrey WDirector | Exercised options | 20,000 | $93.6K |
| November 2, 2026 | Dunn Jeffrey WDirector | Soldpre-planned (10b5-1) | 20,000 | $417.8K |
Who owns SIBN
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Mathew P. Arens13G, passive with 1 related filers | 18.36% | May 7, 2026 |
| Cadian Capital Management, LP13G, passive with 2 related filers | 7.5% | August 14, 2026 |
| Brown Advisory Inc13G, passive with 4 related filers | 5.79% | February 13, 2026 |
| American Century Investment Management, Inc.13G, passive with 3 related filers | 5.3% | February 13, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 168 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| First Light Asset Management, LLC | 8,127,985 | +2,774,795 |
| BlackRock, Inc. | 3,676,259 | +247,718 |
| Cadian Capital Management, LP | 3,347,574 | +1,460,102 |
| American Century Companies Inc | 2,510,963 | +1,898 |
| Brown Advisory Inc | 2,077,134 | -45,198 |
| Granahan Investment Management, LLC | 1,931,182 | +192,085 |
| Vanguard Capital Management LLC | 1,838,499 | +74,186 |
| First Eagle Investment Management, LLC | 1,537,882 | +898,941 |
| Impax Asset Management Group plc | 1,425,010 | 0 |
| Gilder Gagnon Howe & Co LLC | 1,253,042 | +204,526 |
| Paradigm Capital Management Inc | 1,233,200 | +106,700 |
| State Street Corp | 1,214,286 | +84,471 |
| Silvercrest Asset Management Group LLC | 1,158,576 | -86,008 |
| Geode Capital Management, LLC | 1,076,839 | +125,111 |
| Nuveen, LLC | 1,026,036 | -259,475 |
| Champlain Investment Partners, LLC | 896,462 | +18,857 |
| Point72 Asset Management, L.P. | 790,323 | -50,023 |
| Wellington Management Group Llp | 742,857 | -29,755 |
| Dimensional Fund Advisors LP | 708,319 | +89,380 |
| Marshall Wace, Llp | 690,288 | +522,160 |
Insiders
11 insiders reported holding 1,915,071 shares in total, about $49M at the last price.
| Holder | Shares |
|---|---|
| Francis LauraChief Executive Officer, Director | 798,156304,256 held indirectly |
| Recupero Anthony JSee Remarks | 243,418 |
| Maheshwari AnshulChief Op & Financial Officer | 211,250 |
| Pisetsky Michael A.SVP, Ops & Adm/Chief Legal Ofr | 204,61140,167 held indirectly |
| Hinckley Greg KDirector | 105,135 |
| Dunn Jeffrey WDirector | 96,17280,115 held indirectly |
| Davis Timothy E JRDirector | 76,679 |
| Freund John GordonDirector | 54,258 |
| Hilleman Jeryl LDirector | 43,772 |
| Nishimura MikaDirector | 43,673 |
Questions about SIBN
What does SI-BONE, Inc. do?
SI-BONE, Inc. is a company in the Health care sector, listed on NASDAQ as SIBN. Its shares trade on NASDAQ under the ticker SIBN.
What is SI-BONE, Inc.'s net worth?
SI-BONE, Inc. has a market value (market cap) of $1.1B at the latest share price, and shareholders' equity of $184.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is SI-BONE, Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $13.7M on revenue of $220.7M.
How much revenue does SI-BONE, Inc. make?
Over the twelve months to September 30, 2026 SI-BONE, Inc. reported revenue of $220.7M. That is 14.0% more than a year earlier.
When did SI-BONE, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 3, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the insider trade (amended) from November 9, 2026.
When is SI-BONE, Inc.'s next earnings report?
SI-BONE, Inc.'s next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare SIBN with
Follow SIBN
Get an email when SI-BONE, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values SI-BONE, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.